Navigation Links
Kendle to Present at the 2008 Credit Suisse Health Care Conference
Date:11/11/2008

CINCINNATI, Nov. 11 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL) a leading, global full-service clinical research organization, today announced Senior Vice President and Chief Financial Officer Karl "Buzz" Brenkert III will participate in the annual Credit Suisse Health Care Conference. The conference will be held at the Arizona Biltmore Resort & Spa in Phoenix, Nov. 11-14, 2008. Kendle's presentation is scheduled for Friday, Nov. 14 at 10 a.m. Mountain Time (12 p.m. Eastern Standard Time).

(Logo: http://www.newscom.com/cgi-bin/prnh/20080923/CLTU095LOGO )

The public is invited to listen to a live Webcast of Kendle's presentation at http://www.kendle.com (click on the link provided in the Investor Events and Presentations section). An archived version can be accessed approximately three hours following Kendle's presentation and will be available until Dec. 15. Slides accompanying the presentation will be available by 9:00 a.m. Eastern Standard Time on Nov. 14 at http://www.kendle.com under the Investor Events and Presentations section.
Following is a direct link to the Credit Suisse Webcast:

http://w.on24.com/r.htm?e=125759&s=1&k=C0D3FF705148BDBB6A63AEE79C3E2912

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing drugs to market for the benefit of patients worldwide. As one of the fastest-growing global providers of Phase I-IV services, we offer experience spanning 90 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges.

Kendle was recognized by FORTUNE magazine as one of the 100 fastest-growing companies in the United States for 2008. The company also has been recognized as "Top CRO to Work With" in the Thomson CenterWatch 2007 survey of U.S. investigative sites and "Best CRO" for 2007 and 2006 by leading global pharmaceutical publication Scrip World Pharmaceutical News.

Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 1200, Cincinnati, OH 45202 or from the Company's Web site at http://www.kendle.com.


'/>"/>
SOURCE Kendle International Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Kendle Reappoints Former CFO Timothy M. Mooney to Board of Directors
2. Kendle Named a Best Place to Work in Greater Cincinnati
3. Kendle Reports Record 3Q 08 Net Income and Total Business Authorizations
4. Kendle Named to FORTUNE List of 100 Fastest-Growing Companies for 2008
5. Kendle to Present at the UBS Global Life Sciences Conference
6. Kendle Invites You to Attend its Second Quarter 2008 Earnings Conference Call and Webcast
7. Kendle to Host Conference Call and Webcast to Discuss DecisionLine Acquisition and Provide Update on Second Quarter Progress
8. Kendle Expands Global Clinical Pharmacology Capabilities with Acquisition of DecisionLine Clinical Research Corporation
9. Kendle Appoints Patricia Williams Vice President, Commercial Operations
10. Kendle Invites You to Attend its First Quarter 2008 Earnings Conference Call and Webcast
11. Kendle to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers ... 5000 and the 6000i models are higher end machines that use the more unconventional ... spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci has ...
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge (BDC), ... new ways to harness living systems and biotechnology, announced ... (MoMA) in New York City . ... participating students, showcased projects at MoMA,s Celeste Bartos Theater ... Antonelli , MoMA,s senior curator of architecture and design, ...
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
Breaking Biology Technology:
(Date:4/26/2016)... BANGALORE, India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a ... ), and Onegini today announced a partnership to ... banking solutions.      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ... banks to provide their customers enhanced security to ...
(Date:4/14/2016)... AVIV, Israel , April 14, 2016 ... Behavioral Authentication and Malware Detection, today announced the appointment ... already assumed the new role. Goldwerger,s leadership ... BioCatch, on the heels of the deployment of its ... addition, BioCatch,s behavioral biometric technology, which discerns unique cognitive ...
(Date:3/23/2016)... , March 23, 2016 ... erhöhter Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender ... das Unternehmen mit SpeechPro zusammenarbeitet, um erstmals ... Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im Rahmen ...
Breaking Biology News(10 mins):